S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
North Carolina medical marijuana sales begin at Cherokee store
Biden sees a $35 price cap for insulin as a pivotal campaign issue. It’s not that clear-cut
Ukrainian and Western leaders laud US aid package while the Kremlin warns of 'further ruin'
Hawaii lawmakers take aim at vacation rentals after Lahaina wildfire amplifies Maui housing crisis
'Civil War’ continues box-office campaign at No. 1
Conservative Brazilians laud Elon Musk at rally in support of ex-president Bolsonaro
Autoworkers union celebrates breakthrough win in Tennessee and takes aim at more plants in the South
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
North Carolina medical marijuana sales begin at Cherokee store
Biden sees a $35 price cap for insulin as a pivotal campaign issue. It’s not that clear-cut
Ukrainian and Western leaders laud US aid package while the Kremlin warns of 'further ruin'
Hawaii lawmakers take aim at vacation rentals after Lahaina wildfire amplifies Maui housing crisis
'Civil War’ continues box-office campaign at No. 1
Conservative Brazilians laud Elon Musk at rally in support of ex-president Bolsonaro
Autoworkers union celebrates breakthrough win in Tennessee and takes aim at more plants in the South
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
North Carolina medical marijuana sales begin at Cherokee store
Biden sees a $35 price cap for insulin as a pivotal campaign issue. It’s not that clear-cut
Ukrainian and Western leaders laud US aid package while the Kremlin warns of 'further ruin'
Hawaii lawmakers take aim at vacation rentals after Lahaina wildfire amplifies Maui housing crisis
'Civil War’ continues box-office campaign at No. 1
Conservative Brazilians laud Elon Musk at rally in support of ex-president Bolsonaro
Autoworkers union celebrates breakthrough win in Tennessee and takes aim at more plants in the South
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
North Carolina medical marijuana sales begin at Cherokee store
Biden sees a $35 price cap for insulin as a pivotal campaign issue. It’s not that clear-cut
Ukrainian and Western leaders laud US aid package while the Kremlin warns of 'further ruin'
Hawaii lawmakers take aim at vacation rentals after Lahaina wildfire amplifies Maui housing crisis
'Civil War’ continues box-office campaign at No. 1
Conservative Brazilians laud Elon Musk at rally in support of ex-president Bolsonaro
Autoworkers union celebrates breakthrough win in Tennessee and takes aim at more plants in the South

Alterity Therapeutics (ATHE) News Today

$2.04
-0.10 (-4.67%)
(As of 04/19/2024 ET)
SourceHeadline
finance.yahoo.com logoAlterity Therapeutics Parkinson’s Disease and Multiple System Atrophy Data Featured at the American Academy of Neurology (AAN) 2024 Annual Meeting
finance.yahoo.com - April 17 at 8:21 AM
globenewswire.com logoAlterity Therapeutics to Present New Data on ATH434 at the World Orphan Drug Congress USA 2024
globenewswire.com - April 10 at 7:25 AM
finance.yahoo.com logoAlterity Therapeutics Limited (ATHE)
finance.yahoo.com - April 5 at 12:19 PM
globenewswire.com logoAlterity Therapeutics Receives a A$3.9 Million Research & Development Tax Incentive Refund
globenewswire.com - March 26 at 10:25 AM
morningstar.com logoAlterity Therapeutics Ltd ADR ATHE
morningstar.com - March 24 at 11:05 PM
seekingalpha.com logoATHE Alterity Therapeutics Limited
seekingalpha.com - March 22 at 9:44 PM
wsj.com logoAlterity Therapeutics Ltd. ADR
wsj.com - March 22 at 9:44 PM
msn.com logoAlterity Therapeutics drops on capital raise
msn.com - February 23 at 1:58 PM
benzinga.com logoAlterity Therapeutics Stock (NASDAQ:ATHE), Short Interest Report
benzinga.com - February 22 at 7:35 AM
marketbeat.com logo
marketbeat.com - February 21 at 5:42 PM
finance.yahoo.com logoAlterity Therapeutics to Present New Data at the Upcoming American Academy of Neurology 2024 Annual Meeting
finance.yahoo.com - February 20 at 4:16 PM
globenewswire.com logoAlterity Therapeutics to Present New Data at the Upcoming American Academy of Neurology 2024 Annual Meeting
globenewswire.com - February 20 at 10:25 AM
finance.yahoo.com logoAlterity Therapeutics to Participate in the ShareCafe Hidden Gems Webinar This Week
finance.yahoo.com - January 29 at 10:07 AM
finance.yahoo.com logoAlterity Therapeutics Issues Shareholder Letter Highlighting Pipeline Advances and Key Upcoming Milestones
finance.yahoo.com - January 22 at 9:05 AM
finanznachrichten.de logoALTERITY THERAPEUTICS LIMITED: Alterity Therapeutics Appoints Phillip Hains as Chief Financial Officer
finanznachrichten.de - December 21 at 10:07 AM
finance.yahoo.com logoAlterity Therapeutics to Host Webcast to Discuss ATH434 Efficacy Data in Primates and Recent Clinical Progress
finance.yahoo.com - December 4 at 7:16 PM
marketwatch.com logoAlterity Therapeutics Shares Up Fivefold on New Parkinson's Drug Data
marketwatch.com - December 4 at 2:16 PM
msn.com logoWhy Is Neurodegenerative Disease-Focused Alterity Therapeutics Stock Trading Over 200% Higher Today?
msn.com - December 4 at 2:16 PM
finance.yahoo.com logoBiotech Alterity Jumps On Upbeat Parkinson's Treatment Clinical Trial Data
finance.yahoo.com - December 4 at 2:16 PM
finance.yahoo.com logoAlterity Therapeutics Reports Positive Efficacy Data for ATH434 in a Primate Model of Parkinson’s Disease
finance.yahoo.com - December 4 at 8:15 AM
finance.yahoo.com logoAlterity Therapeutics Announces Presentation of Novel Biomarker Data for Evaluation of Multiple System Atrophy
finance.yahoo.com - November 27 at 8:57 AM
finance.yahoo.com logoAlterity Therapeutics Limited's (ASX:ATH) CEO Compensation Is Looking A Bit Stretched At The Moment
finance.yahoo.com - November 22 at 8:08 PM
msn.com logoAlterity Therapeutics, Edesa Biotech among healthcare movers
msn.com - November 22 at 3:07 PM
marketwatch.com logoAlterity Therapeutics ADRs Shares Dive 31% on Raised Capital
marketwatch.com - November 22 at 3:07 PM
marketbeat.com logo
marketbeat.com - November 20 at 6:37 AM
finanznachrichten.de logoALTERITY THERAPEUTICS LIMITED: Alterity Therapeutics Announces Presentation of New Data Demonstrating Novel Mechanisms of ATH434
finanznachrichten.de - November 16 at 9:22 AM
finance.yahoo.com logoAlterity Therapeutics Announces Presentation of New Data Demonstrating Novel Mechanisms of ATH434
finance.yahoo.com - November 16 at 9:22 AM
finanznachrichten.de logoALTERITY THERAPEUTICS LIMITED: Alterity Therapeutics Completes Enrolment in ATH434-201 Phase 2 Clinical Trial in Multiple System Atrophy
finanznachrichten.de - November 8 at 10:47 AM
finance.yahoo.com logoAppendix 4C – Q1 FY24 Quarterly Cash Flow Report
finance.yahoo.com - October 30 at 12:00 PM
finance.yahoo.com logoAlterity Therapeutics Presents New Data on Multiple System Atrophy, a Rare Parkinsonian Disorder
finance.yahoo.com - August 31 at 8:54 AM
finance.yahoo.com logoAlterity Therapeutics Granted New Composition of Matter Patent in Europe for Neurodegenerative Diseases including Parkinson’s and Alzheimer’s
finance.yahoo.com - August 23 at 8:45 AM
technews.tmcnet.com logoAlterity Therapeutics Rare Disease Natural History Study to be Featured at the International Congress of Parkinson's Disease and Movement Disorders
technews.tmcnet.com - August 22 at 5:14 PM
finance.yahoo.com logoAlterity Therapeutics Rare Disease Natural History Study to be Featured at the International Congress of Parkinson’s Disease and Movement Disorders
finance.yahoo.com - August 22 at 5:14 PM
finance.yahoo.com logoAlterity Therapeutics Receives a $4.74 million Research & Development Tax Incentive Refund
finance.yahoo.com - August 15 at 7:49 AM
finance.yahoo.com logoAppendix 4C – Q4 FY23 Quarterly Cash Flow Report
finance.yahoo.com - July 31 at 10:36 AM
finance.yahoo.com logoAlterity Therapeutics Phase 2 Data Monitoring Committee Recommends Continuing Clinical Trial as Planned
finance.yahoo.com - July 26 at 9:27 PM
finance.yahoo.com logoAlterity Therapeutics to Present in MST Access Rare Diseases, Rich Returns Forum on 22 June 2023
finance.yahoo.com - June 21 at 8:14 AM
finance.yahoo.com logoAlterity Therapeutics Initiates Second Phase 2 Study in Rare Parkinsonian Disorder
finance.yahoo.com - May 30 at 12:00 PM
finance.yahoo.com logoAlterity Therapeutics CEO David Stamler to Present at the SHARE Series Monday Management Update on Monday, May 22, 2023
finance.yahoo.com - May 19 at 8:54 AM
finance.yahoo.com logoAppendix 4C – Q3 FY23 Quarterly Cash Flow Report
finance.yahoo.com - May 10 at 12:04 PM
finance.yahoo.com logoAlterity Therapeutics Enrolls First Patient in Australia in ATH434 Global Phase 2 Clinical Trial in Multiple System Atrophy
finance.yahoo.com - May 10 at 12:04 PM
finance.yahoo.com logoAlterity Therapeutics Presents Promising Wearable Sensor Data from the bioMUSE Natural History Study at the American Academy of Neurology
finance.yahoo.com - April 26 at 7:42 AM
msn.com logoAlterity gets US patent, inks licensing pact to advance asset for Alzheimer's
msn.com - March 14 at 9:24 AM
finance.yahoo.com logoAlterity Therapeutics Announces Granting of New Composition of Matter Patent and Exclusive License Agreement for Assets in Alzheimer’s Disease
finance.yahoo.com - March 14 at 9:24 AM
finance.yahoo.com logoAlterity Therapeutics Enrolls First Patient in Italy in ATH434 Phase 2 Clinical Trial in Multiple System Atrophy
finance.yahoo.com - March 8 at 10:12 AM
finance.yahoo.com logoAppendix 4C - Q2 FY23 Quarterly Cash Flow Report
finance.yahoo.com - January 31 at 10:21 AM
finance.yahoo.com logoAlterity's Parkinson's Candidate Prevents Loss Of Brain Cells In Animal Model
finance.yahoo.com - January 30 at 5:39 PM
msn.com logoAlterity stock rises ~10% as ATH434 shows promise in Parkinson’s animal model study
msn.com - January 30 at 12:38 PM
technews.tmcnet.com logoAlterity's ATH434 Prevents Loss of Brain Cells in Parkinson's Disease Animal Model
technews.tmcnet.com - January 30 at 7:37 AM
finance.yahoo.com logoAlterity’s ATH434 Prevents Loss of Brain Cells in Parkinson’s Disease Animal Model
finance.yahoo.com - January 30 at 7:37 AM
Get Alterity Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for ATHE and its competitors with MarketBeat's FREE daily newsletter.

SHOCKING Crypto Leak… (Ad)

A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024.

Claim your free seat by clicking here now.

ATHE Media Mentions By Week

ATHE Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

ATHE
News Sentiment

1.48

0.49

Average
Medical
News Sentiment

ATHE News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

ATHE Articles
This Week

1

0

ATHE Articles
Average Week

Get Alterity Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for ATHE and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

This page (NASDAQ:ATHE) was last updated on 4/21/2024 by MarketBeat.com Staff

From Our Partners